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I N T R O D U C T I O N
In the CNS, nicotinic acetylcholine receptors (nAChRs) play an important role in short-term memory, attention, and anxiety (Levin 1992; Ohno et al. 1993) . The central nAChRs have a modulatory role in transmitter release. Nicotine, a nicotinic receptor agonist and a major constituent of tobacco, increases release of several neurotransmitters (Role and Berg 1996) and enhances the frequency of spontaneous postsynaptic currents mediated by glutamate and GABA (Alkondon et al. 1999; Gray et al. 1996; McGehee et al. 1995; McMahon et al. 1994) . Although it has been reported that activation of nicotinic receptors enhances evoked glutamatergic transmission (McGehee et al. 1995) , the effects of nicotine on electrically evoked GABAergic transmission have not been examined. Furthermore, the effects of low concentrations, close to the steadystate level of nicotine in blood provided by cigarette smoking (Benowitz et al. 1989) , on GABAergic synaptic function need to be tested.
In the present study, we examined the effects of nicotine on GABAergic transmission in the chick lateral spiriform nucleus (SPL), a thalamic pretectal nucleus containing a high-density of 3 H-nicotine binding sites (Sorenson and Chiappinelli 1990) and GABA A receptors (Veenman et al. 1994) . Our data indicate that unlike its effect on spontaneous GABA currents, nicotine enhanced evoked GABAergic transmission only at low concentrations (50 -100 nM) and caused a reduction in evoked responses at 0.5-1.0 M.
M E T H O D S
Brain slices (400 m) containing the SPL were prepared from chick embryos (18 days of incubation). Slices were cut with a Vibroslice (Campden Instruments, Sileby, UK) in cold buffer bubbled with 95% O 2 -5% CO 2 . The composition of the external recording buffer was (in mM) 126 NaCl, 2.5 KCl, 2.5 CaCl 2 , 1.3 MgCl 2 , 1.2 Na 2 HPO 4 , 25 NaCO 3 , and 10 glucose. The slice was continuously perfused (ϳ4 ml/min) at room temperature (23°C) in a recording chamber as previously described (Guo et al. 1998) . Drugs were applied by bath perfusion except GABA, which was given by pressure ejection through a fast perfusion system (ALA Scientific Instruments, Westbury, NY).
The SPL neurons were visualized under an Axioskop fixed-stage microscope (Zeiss, Oberkochen, Germany) at ϫ400 for voltage-clamp recording. Patch pipettes were made by a two-stage microelectrode puller and had resistances of 4 -7 M⍀ after filling with internal solution containing (in mM) 140 KCl, 10 HEPES, 5.5 EGTA, 2 Mg-ATP, 2 MgCl 2 , and 5 QX314 (added to block sodium spikes). Conventional patch-clamp techniques were used with an Axoclamp-2A amplifier (Axon Instruments, Burlingame, CA). Holding potential was Ϫ60 to Ϫ70 mV. Approximately half-maximal postsynaptic current (PSC) was electrically evoked through a bipolar electrode placed adjacent to the medial side of the SPL at 0.05 Hz. The evoked PSC was recorded with a video cassette recorder. The data were sampled by pClamp7 software through a Digidata 1200 interface. The figures were plotted with SigmaPlot.
Drugs were obtained as follows: (Ϫ)-nicotine bitartrate, bicuculline methiodide (BIC), and ␥-amino-n-butyric acid (GABA) from Sigma (St. Louis, MO); lidocaine N-ethyl bromide (QX314) from RBI (Natick, MA); tetrodotoxin (TTX) from Calbiochem (San Diego, CA); and dihydro-␤-erythroidine (DH␤E) was a gift from Merck, Sharp & Dohme Research Labs (Rahway, NJ). The data were expressed as means Ϯ SE; differences between means were examined by the paired t-test unless otherwise indicated.
R E S U L T S
Whole cell recordings demonstrated that in SPL neurons, spontaneous events were fully blocked ( Fig. 1A) and electrically evoked responses (medial placement of stimulating electrode) were suppressed by 98 Ϯ 1% (mean Ϯ SE, n ϭ 8, Fig.  1B ) in the presence of the GABA A receptor antagonist bicuculline (20 M), indicating that these synaptic activities were primarily GABAergic. These GABAergic events were inward currents due to the presence of KCl-containing internal solution in the patch pipettes.
Bath application of nicotine to slices containing the SPL produced a sustained postsynaptic inward current and an increase in spontaneous GABAergic synaptic activity as previ-
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. ously described (McMahon et al. 1994) . Nicotine increased the frequency of spontaneous GABA currents in a dose-dependent manner ( Fig. 2A) . Overall, there were 42 Ϯ 11% (n ϭ 12), 154 Ϯ 25% (n ϭ 8), and 465 Ϯ 76% (n ϭ 7) increases in spontaneous events in the presence of 0.1, 0.25, and 1.0 M nicotine, respectively. Nicotine also caused a sustained inward current of 20 Ϯ 4, 63 Ϯ 12, and 184 Ϯ 42 (pA) at 0.1 M (n ϭ 12), 0.25 M (n ϭ 8), and 1.0 M (n ϭ 7), respectively.
A different pattern was observed for nicotine effects on electrically evoked GABAergic transmission. Whereas nicotine dose-dependently increased the frequency of spontaneous currents, evoked GABAergic transmission was only enhanced at concentrations of 50 -100 nM (Fig. 2B) . At 50 nM, nicotine produced a significant 9 Ϯ 2.3% increase in evoked GABAergic current (834 Ϯ 190 pA in nicotine, 743 Ϯ 168 pA in control, n ϭ 5, P Ͻ 0.05). In 14 cells tested, 100 nM nicotine significantly increased evoked postsynaptic GABAergic currents by 19 Ϯ 3.4% (954 Ϯ 159 pA in nicotine, 804 Ϯ 138 pA in control, P Ͻ 0.001). In contrast, nicotine at high concentrations (0.5-1.0 M) caused a significant reduction in the evoked GABAergic transmission (Fig. 2B ). In seven cells tested, nicotine (0.5-1.0 M) caused a 114 Ϯ 16 pA reduction in the evoked GABAergic current from the control level of 918 Ϯ 184 pA (P Ͻ 0.001). At an intermediate concentration (0.25 M), nicotine had no significant effect on evoked postsynaptic GABAergic current (712 Ϯ 42 pA in 0.25 M nicotine compared with control level of 746 Ϯ 123 pA, n ϭ 8). At a very low concentration (25 nM), nicotine also had no significant effect on evoked GABAergic currents (760 Ϯ 79 pA in nicotine, 687 Ϯ 44 pA in control, P Ͼ 0.3, n ϭ 5). Further, nicotine (100 nM) enhanced the evoked GABAergic current without having any significant effect on the mean amplitude of GABAergic spontaneous events. In nine cells tested, the mean amplitude of spontaneous GABAergic events was 217 Ϯ 13 pA in control and 212 Ϯ 13 pA in the presence of 100 nM nicotine (P Ͼ 0.6).
Dihydro-␤-erythroidine (DH␤E), a nicotinic receptor antagonist, blocked the effects of nicotine on electrically evoked GABAergic transmission (Fig. 3 ). In three cells tested, nicotine alone (100 nM, 1.0 M) caused a 207 Ϯ 37 pA increase (P Ͻ 0.05) and a 296 Ϯ 78 pA reduction in evoked GABAergic current, respectively, from control values of 959 Ϯ 112 and 1,186 Ϯ 109 pA. However, in the presence of 60 M DH␤E, nicotine (0.1, 1.0 M) only altered evoked GABAergic current by 65 Ϯ 79 (P Ͼ 0.6) and 55 Ϯ 43 pA (P Ͼ 0.5), respectively.
The effect of nicotine on the postsynaptic current induced by exogenous application of GABA was examined in the presence of 0.5 M TTX. Nicotine had no significant effect on the postsynaptic current produced by pressure ejection of GABA onto SPL neurons. In five cells, the control inward current elicited by GABA (30 -50 M) was 3.5 Ϯ 0.36 nA and 98 Ϯ 2.3% of control in the presence of 0.5-1.0 M nicotine. At 100 nM nicotine, there was also no significant change from control (only 2 Ϯ 2.6% decrease, P Ͼ 0.4, n ϭ 3).
D I S C U S S I O N
Nicotine, a potent neuromodulator in the CNS, enhances the release of a variety of transmitters and increases synaptic transmission mediated by glutamate (McGehee et al. 1995; Role and Berg 1996) . In the present study, we demonstrate that low concentrations of nicotine (50 -100 nM) enhance evoked GABAergic currents in chick SPL neurons. Higher concentrations of nicotine (0.5-1.0 M) reversibly decrease evoked GABAergic currents in SPL neurons. This is in contrast to the dose-dependent enhancement of the frequency of spontaneous GABAergic currents produced by nicotine.
Although nicotine in blood can reach a peak concentration of 0.5 M after cigarette consumption (Henningfield et al. 1993) , steady-state nicotine levels are generally ϳ100 nM (Benowitz et al. 1989; Russell 1989) , and those in brain are equivalent to or even greater than those in blood. The present study indicates FIG. 3. Nicotinic receptor antagonist, dihydro-␤-erythroidine (DH␤E), blocks nicotinic effects on evoked GABAergic transmission in SPL neurons. Top: nicotine reversibly enhanced evoked transmission at a low concentration (100 nM) in A, but reduced it at 1.0 M (B). Middle: DH␤E (60 M) greatly reduced nicotine effects on evoked synaptic responses (C and D). Bottom: after washing out DH␤E (E and F). Traces are averages of 7 evoked responses. Recordings are from the same cell. V h , Ϫ70 mV.
that concentrations of nicotine similar to steady-state levels found in smokers significantly increase both spontaneous and evoked GABAergic synaptic activities. Considerable heterogeneity exists in the subunit compositions and pharmacological properties of central nAChRs, including those located on presynaptic terminals (Alkondon et al. 1999; Guo et al. 1998) . Particularly relevant to the present investigation is that nicotine rapidly desensitizes (within ms) some nAChRs, including most ␣7-containing receptors. The bath application method used to apply nicotine in the present study is relatively slow, and thus it is unlikely that the effects we observe, which persisted throughout 1-to 2-min exposures to nicotine, were due to activation of such rapidly desensitizing receptors. Likewise, in smokers exposed during the day to comparable steady-state levels of nicotine, most of these receptors would presumably be desensitized.
Both pre-and postsynaptic mechanisms could contribute to the nicotinic effect on evoked GABAergic transmission. Because nicotine had no significant effect on the postsynaptic currents elicited by exogenous GABA (30 -50 M), the postsynaptic sensitivity to GABA was unchanged by activation of nicotinic receptors. In these experiments GABA was applied using a fast perfusion system to mimic evoked release of transmitter. It should be noted that there remain some differences between this approach and electrically evoking GABA release, especially in the magnitude of the currents generated by the two techniques, with approximately fourfold higher currents produced by exogenous GABA. Because no evidence was obtained for nicotine altering postsynaptic GABA currents, a presynaptic mechanism most likely accounts for the observed effects of nicotine. Nicotine also enhances glutamatergic transmission in the CNS by a presynaptic mechanism involving an increase in presynaptic [Ca 2ϩ ] i (Gray et al. 1996; McGehee et al. 1995) .
There are several possible explanations for the decrease in evoked transmission observed at higher concentrations of nicotine. The first hypothesis requires two subtypes of nicotinic receptors on the GABAergic afferents. The first subtype enhances spontaneous GABA release, and the second subtype, located nearby GABA release sites, enhances evoked GABA release at low concentrations of nicotine, but desensitizes at higher concentrations of the agonist. This hypothesis would be feasible if there was ongoing acetylcholine (ACh) release that up-regulated GABAergic transmission during control stimulation. However, because DH␤E, a nicotinic receptor antagonist, did not alter evoked GABAergic transmission elicited by stimulating the medial side of the SPL (see Fig. 3 ), we have no evidence for ongoing ACh release at this site. Furthermore, fibers containing choline acetyltransferase are not present on the medial side of the SPL.
[Cholinergic fibers are present on the lateral side of the nucleus, and electrical stimulation of these lateral fibers does evoke postsynaptic nicotinic responses in SPL neurons (Nong et al. 1999) ]. The second hypothesis is that high concentrations of nicotine may cause the release of other inhibitory transmitters (Reiner et al. 1982a,b) which in turn reduce evoked GABAergic responses. Alternatively, the reduction in evoked GABAergic transmission induced by higher concentrations of nicotine may be mediated through presynaptic inhibition (Clements et al. 1987; Ryall 1978) resulting from depolarization of GABAergic terminals by nicotine.
Enhanced spontaneous GABA release induced by nicotine could also contribute to the reduction of evoked GABAergic transmission at high concentrations of the agonist. The released GABA could act on presynaptic GABA B receptors to reduce GABAergic transmission (Davies and Collingridge 1993) . Increased spontaneous release of GABA might also lead to a decrease in the amount of GABA released in response to electrical stimulation. The significance of nicotinic enhancement of evoked GABAergic transmission in the brain is potentially far-reaching, because GABA is the principal inhibitory neurotransmitter in the brain. It remains to be seen whether the effects we observe here are representative of the relationship between nAChRs and GABAergic transmission in other regions of the brain.
In summary, nicotine increased spontaneous GABAergic synaptic currents recorded from chick SPL neurons in a dosedependent manner. At low concentrations (50 -100 nM), nicotine enhanced evoked GABAergic transmission, whereas higher concentrations of nicotine reduced the evoked GABAergic current. Moreover, the nicotinic effect on GABAergic transmission appears to be through a presynaptic mechanism.
